Trial Profile
Study of dapagliflozin in patients with inadequately controlled type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Oct 2018 New trial record